The biosynthetic pathways of BIAs have not been fully elucidated, mainly due to the complex transformations from 1-BIAs to various types of BIAs scaffolds and the subsequent downstream modifications, including C-C coupling, C-O coupling, hydroxylation, and methylation, etc. (Li et al., 2024; Meng et al., 2024). This study reported the de novo transcriptome of S. yunnanensis, and through the combined analysis of the transcriptome, metabolome, and genome, identified 18 candidate genes involved in BIA biosynthesis in S. yunnanensis. The functions of three CYP80s were validated in vitro, they specifically catalyzed the C-C coupling of (S)- or (R)-configured 1-BIA substrates, resulting in the formation of aporphines or protoaporphines. This is an important step in the biosynthetic pathways of aporphines (Li et al., 2024).
In medicinal plants where roots or rhizomes are used, the active components are often highly concentrated in the underground parts, with corresponding functional genes and regulatory factors showing significantly higher expression levels compared to the aboveground parts (He et al., 2018; Liu et al., 2017; Liu et al., 2023; Tong et al., 2022; Wang et al., 2015; Zhan et al., 2019). In this study, we analyzed the representative BIAs of S. yunnanensis and found that the major active component, crebanine and three other BIAs were highly accumulated in the roots, similar to other root-based medicinal plants. Notably, no upstream 1-BIAs were detected in the metabolomes of any tissues, possibly due to their complete consumption or concentrations below the detection limit. Furthermore, under the extraction and detection conditions of this study, the representative bisbenzylisoquinoline alkaloid, cepharanthine, was not detected.
Then we sequenced the transcriptomes of S. yunnanensis using next-generation sequencing, followed by de novo assembly and functional annotation. Previous studies have shown that P450s are involved in almost the entire biosynthetic pathways of BIAs, specifically CYP80, which participates in hydroxylation and downstream C-O and C-C coupling reactions (An et al., 2024; Hao et al., 2024; Li et al., 2024; Meng et al., 2024). CYP719 catalyzed the formation of the methylenedioxy bridge (Hori et al., 2018; Ikezawa et al., 2003; Li et al., 2024; Menendez-Perdomo & Facchini, 2023), a characteristic group of many active BIA components, including crebanine. We identified 25 transcripts annotated as “CYP80” and 11 were annotated as “CYP719” in the de novo transcriptome of S. yunnanensis. Through annotation and sequence alignment, we identified 26 candidate transcripts involved in 10 steps of the BIA biosynthetic pathways. The heatmap showed that, except for a few genes, the majority were not specifically expressed in the roots but were highly expressed across multiple tissues. This pattern of metabolite accumulation and differential gene expression levels, while uncommon, is not unprecedented in BIA-producing plants. Similar mechanisms involving transporter proteins facilitating the movement of compounds within the plant have been reported previously in C. japonica (Sakai et al., 2002; Shitan et al., 2003)d somniferum (Dastmalchi et al., 2019). We speculate that similar mechanisms may also exist in S. yunnanensis, facilitating the internal transfer of compounds through processes such as endocytosis and exocytosis. In summary, the transcriptome data obtained in this study are valuable for elucidating the biosynthetic pathways of BIAs, including crebanine.
BGCs, composed of tightly arranged genes that collectively participate in the biosynthesis of specific metabolites, allow organisms to coordinate and efficiently regulate gene expression and synergistic metabolic reactions (Li et al., 2017). With the reported high-quality genome of S. yunnanensis (Leng et al., 2024), this study also examined the chromosomal localization of the 18 candidate genes and found a tendency for several candidate genes to cluster. Further collinearity analysis showed that this clustering phenomenon is conserved among different Stephania species, indicating important functions in their evolutionary processes. Notably, the tandem duplication of SyCYP80Q5-1 and SyCYP80Q5-2 on chromosome 1 of S. yunnanensis was not conserved among different species, whereas another SyCYP80Q5-3 gene on chromosome 13 was widely conserved. This might explain why all Stephania species can produce aporphines and protoaporphines, but differ in the types and amounts they contain. Furthermore, the number of CYP80Q5 copies in S. yunnanensis was significantly higher than CYP80G6, which was consistent with the finding that there are more type II aporphines present in S. yunnanensis. In conclusion, the differences and conservation of the BIA biosynthetic pathways in Stephania suggest that there are still variations within the genus. This may explain why there are significant differences in the types and contents of BIAs among different Stephania species.
As an important gene family in the BIA biosynthetic pathways, CYP80, this study further validated the functions of three CYP80s from S. yunnanensis in vitro, showing that they all had the ability to catalyze substrate C-C coupling with configurational selectivity. Specifically, SyCYP80G6 specifically catalyzed the production of corresponding aporphines or protoaporphines from (S)-type substrates; SyCYP80Q5-1 and SyCYP80Q5-3 specifically catalyzed the production of corresponding protoaporphines, the precursor of type Ⅱ aporphines, from (R)-type substrates. The functions of CYP80 are complex and diverse, and there might be some evolutionary correlation. It is noteworthy that, although SyCYP80G6 can also catalyze (S)-type substrates to produce aporphines and protoaporphines, similar to other CYP80Gs, we did not detect any representative reported (S)-type aporphines, such as magnoflorine or mecambroline, in S. yunnanensis. However, the expression level of SyCYP80G6 is not low. This discrepancy between metabolites and gene expression suggests that there may be mechanisms in S. yunnanensis's aporphine biosynthesis that we have yet to understand. It is possible that the metabolic flux is diverted towards (R)-reticuline, leading to the biosynthesis of (R)-type aporphines, morphinans, and protoberberines.
In conclusion, the combined approach of metabolite analysis and transcriptome sequencing identified 26 candidate transcripts responsible for the biosynthesis of BIAs, including crebanine, in S. yunnanensis, these genes might be responsible for BIAs biosynthesis in S. yunnanensis. Furthermore, genome analysis of the 18 candidate genes showed clustering on chromosomes, suggesting the presence of related BGCs, and collinearity analysis indicated these BGCs are conserved among different Stephania species. Finally, we identified three CYP80s from the S. yunnanensis transcriptome data as involved in BIAs biosynthesis using in vitro enzymatic reaction. Overall, our work provides valuable genetic information on S. yunnanensis and reveals the biosynthesis of BIAs in this medicinal plant.